BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Prostate cancer AND PSIP1, PSIP2, 11168, ENSG00000164985
5 results:

  • 1. Glucocorticoid Receptor Regulates and Interacts with LEDGF/p75 to Promote Docetaxel Resistance in prostate cancer Cells.
    Sanchez-Hernandez ES; Ochoa PT; Suzuki T; Ortiz-Hernandez GL; Unternaehrer JJ; Alkashgari HR; Diaz Osterman CJ; Martinez SR; Chen Z; Kremsky I; Wang C; Casiano CA
    Cells; 2023 Aug; 12(16):. PubMed ID: 37626856
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. The LEDGF/p75 Integrase Binding Domain Interactome Contributes to the Survival, Clonogenicity, and Tumorsphere Formation of Docetaxel-Resistant prostate cancer Cells.
    Ortiz-Hernandez GL; Sanchez-Hernandez ES; Ochoa PT; Elix CC; Alkashgari HR; McMullen JRW; Soto U; Martinez SR; Diaz Osterman CJ; Mahler M; Roy S; Casiano CA
    Cells; 2021 Oct; 10(10):. PubMed ID: 34685704
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Hepatoma-derived growth factor-related protein 2 promotes DNA repair by homologous recombination.
    Baude A; Aaes TL; Zhai B; Al-Nakouzi N; Oo HZ; Daugaard M; Rohde M; Jäättelä M
    Nucleic Acids Res; 2016 Mar; 44(5):2214-26. PubMed ID: 26721387
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Frequent mutations in chromatin-remodelling genes in pulmonary carcinoids.
    Fernandez-Cuesta L; Peifer M; Lu X; Sun R; Ozretić L; Seidal D; Zander T; Leenders F; George J; Müller C; Dahmen I; Pinther B; Bosco G; Konrad K; Altmüller J; Nürnberg P; Achter V; Lang U; Schneider PM; Bogus M; Soltermann A; Brustugun OT; Helland Å; Solberg S; Lund-Iversen M; Ansén S; Stoelben E; Wright GM; Russell P; Wainer Z; Solomon B; Field JK; Hyde R; Davies MP; Heukamp LC; Petersen I; Perner S; Lovly C; Cappuzzo F; Travis WD; Wolf J; Vingron M; Brambilla E; Haas SA; Buettner R; Thomas RK
    Nat Commun; 2014 Mar; 5():3518. PubMed ID: 24670920
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Autoantibody signatures as biomarkers to distinguish prostate cancer from benign prostatic hyperplasia in patients with increased serum prostate specific antigen.
    O'Rourke DJ; DiJohnson DA; Caiazzo RJ; Nelson JC; Ure D; O'Leary MP; Richie JP; Liu BC
    Clin Chim Acta; 2012 Mar; 413(5-6):561-7. PubMed ID: 22146597
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.